People · Operator
Named in public records as an officer, director or promoter · active 2014–2014 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nexstim Plc | — | Biotechnology | Seed | $3.7M | $166.4M | 2014 |
Katya ` Smirnyagina at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Katya ` Smirnyagina on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Casper Breum | 1 | 5 |
| Johan Christenson | 1 | 3 |
| Ken Charhut | 1 | 3 |
| Rene Kuijten | 1 | 2 |
| Tim Irish | 1 | 1 |
| John Hardin | 1 | 1 |
| Henri Hannula | 1 | 1 |
| Gustaf Jarnefelt | 1 | 1 |
| Mikko Karvinen | 1 | 1 |
| Juha Vapaavuori | 1 | 1 |
| Janne Huhtala | 1 | 1 |
| Rainer Harjunpaa | 1 | 1 |
| Petriina Puolakka | 1 | 1 |
| Jarmo Laine | 1 | 1 |
| Olli Riikkala | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.